fig1
![The role of exosomal microRNAs; focus on clinical applications in breast cancer](https://image.oaes.cc/0ec3fe4a-cb69-436e-a1a2-09a769317168/3132.fig.1.jpg)
Figure 1. MicroRNAs and the putative target genes associated with drug resistance in breast cancer cells. Arrows indicate activation and bar indicate inhibition. Adr: adriamycin; CSC: cancer stem cell; Doc: docetaxel; Dox: doxorubicin; EMT: epithelial-to-mesenchymal transition; Epi: epirubicin; Gem: gemcitabine; Pac: paclitaxel